Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer
Journal of Clinical Investigation · 01.04.2021 · 131 (7)
DOI: 10.1172/jci142677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.04.2021. Verfasst von Helen E Burston und 12 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Autocrine Communication, MAP Kinase Signaling System, Wnt Signaling Pathway. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada.
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
- Institut du Cancer de Montréal, Montréal, Quebec, Canada.
- Banting and Best Department of Medical Research, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
- Penn Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Antibody Solutions, Santa Clara, California, USA.
Förderung
- CIHR
Zitieren
APA
Burston, H. E., Kent, O. A., Communal, L., Udaskin, M. L., Sun, R. X., Brown, K. R., Jung, E., Francis, K. E., La Rose, J., Lowitz, J., Drapkin, R., Mes-Masson, A. M., & Rottapel, R. (2021). Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer. Journal of Clinical Investigation, 131(7). https://doi.org/10.1172/jci142677
Vancouver
Burston HE, Kent OA, Communal L, Udaskin ML, Sun RX, Brown KR, et al. Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer. Journal of Clinical Investigation. 2021;131(7). doi:10.1172/jci142677
BibTeX
@article{Burston2021,
author = {Burston, Helen E and Kent, Oliver A and Communal, Laudine and Udaskin, Molly L and Sun, Ren X and Brown, Kevin R and Jung, Euihye and Francis, Kyle E and La Rose, Jose and Lowitz, Joshua and Drapkin, Ronny and Mes-Masson, Anne-Marie and Rottapel, Robert},
title = {Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer},
journal = {Journal of Clinical Investigation},
year = {2021},
volume = {131},
number = {7},
doi = {10.1172/jci142677}
}
EUVIMED